Mapping technological capabilities into product markets and competitive advantage: the case of cholesterol drugs
暂无分享,去创建一个
[1] David Besanko,et al. Economics of Strategy , 1995 .
[2] J. Hausman. Specification tests in econometrics , 1978 .
[3] David J. Teece,et al. Product Emulation Strategies in The Presence of Reputation Effects And Network Externalities: Some Evidence From The Minicomputer Industry , 1990 .
[4] Margaret A. Peteraf. The cornerstones of competitive advantage: A resource‐based view , 1993 .
[5] B. Wernerfelt,et al. A Resource-Based View of the Firm , 1984 .
[6] David J. Miller,et al. The Resource-Based View of the Firm in Two Environments: The Hollywood Film Studios From 1936 to 1965 , 1996 .
[7] M. Porter. Towards a dynamic theory of strategy , 1991 .
[8] Ernst R. Berndt,et al. The Practice of Econometrics: Classic and Contemporary. , 1992 .
[9] Constance E. Helfat,et al. Know-how and asset complementarity and dynamic capability accumulation : The case of R&D , 1997 .
[10] Y. Mundlak. On the Pooling of Time Series and Cross Section Data , 1978 .
[11] P. Vagelos,et al. Are prescription drug prices high? , 1991, Science.
[12] R. Rumelt. Towards a Strategic Theory of the Firm , 1984 .
[13] D. Teece. Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy , 1993 .
[14] D. Teece,et al. DYNAMIC CAPABILITIES AND STRATEGIC MANAGEMENT , 1997 .
[15] D. Teece. Profiting from technological innovation: Implications for integration, collaboration, licensing and public policy , 1993 .
[16] J. Barney,et al. Organizational Culture: Can It Be a Source of Sustained Competitive Advantage? , 1986 .
[17] C. Prahalad,et al. The core competence of the corporation’, Harvard Business Review, Vol. pp. . , 1990 .
[18] Z. Griliches,et al. Price Indexes And Quality Change , 1973 .
[19] Clayton M. Christensen,et al. CUSTOMER POWER, STRATEGIC INVESTMENT, AND THE FAILURE OF LEADING FIRMS , 1996 .
[20] R. Henderson. The evolution of integrative capability: innovation in cardiovascular drug discovery , 1994 .
[21] D. B. Montgomery,et al. First-mover (dis)advantages: Retrospective and link with the resource-based view , 1998 .
[22] Karel Cool,et al. Asset stock accumulation and sustainability of competitive advantage , 1989 .
[23] J. Stavins. Model Entry and Exit in a Differentiated-Product Industry: The Personal Computer Market , 1995 .
[24] K. Lancaster,et al. Consumer Demand. A New Approach. , 1972 .
[25] Karel Cool,et al. Performance differences among strategic group members , 1988 .
[26] A. Cooper,et al. The role of firm resources and organizational attributes in determining entry timing: a cross-industry study , 1998 .
[27] S. Rosen. Hedonic Prices and Implicit Markets: Product Differentiation in Pure Competition , 1974, Journal of Political Economy.
[28] K. R. Conner,et al. A Resource-Based Theory of the Firm: Knowledge Versus Opportunism , 1996 .